Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia
Clinical trial NCT01408732 · COMPLETED
Trial details
- NCT number
- NCT01408732
- Sponsor
- University of Minnesota
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2014-09-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.